Literature DB >> 20101455

Spatial clustering of myelodysplastic syndromes (MDS) in the Seattle-Puget Sound region of Washington State.

Michelle E Ross1, Jon Wakefield, Scott Davis, Anneclaire J De Roos.   

Abstract

OBJECTIVES: Incidence of myelodysplastic syndromes (MDS) has been described in the United States since its inclusion in the Surveillance, Epidemiology, and End Results program in 2001, and the Seattle-Puget Sound region of Washington State has among the highest rates of the registries. In this investigation, we described small-scale incidence patterns of MDS within the Seattle-Puget Sound region from 2002 to 2006 and identified potential spatial clusters to inform planning of future studies of MDS etiology.
METHODS: We used a spatial disease mapping model to estimate smoothed relative risks for each census tract and to describe the spatial component of variability in the incidence rates. We also used two methods to describe the location of potential MDS clusters: the approach of Besag and Newell and the Kulldorff spatial scan statistic.
RESULTS: Our findings from all three approaches indicated the most likely areas of increased MDS incidence were located on Whidbey Island in Island County.
CONCLUSION: Interpretation is limited because our data are based on the residential location of the MDS case only at the time of diagnosis. Nevertheless, inclusion of identified cluster regions in future population-based research and investigation of individual-level exposures could shed light on environmental risk factors for MDS.

Entities:  

Mesh:

Year:  2010        PMID: 20101455      PMCID: PMC3196606          DOI: 10.1007/s10552-010-9509-6

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  4 in total

1.  Disease mapping and spatial regression with count data.

Authors:  Jon Wakefield
Journal:  Biostatistics       Date:  2006-06-29       Impact factor: 5.899

Review 2.  Organic solvents and cancer.

Authors:  E Lynge; A Anttila; K Hemminki
Journal:  Cancer Causes Control       Date:  1997-05       Impact factor: 2.506

3.  Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

Authors:  Dana E Rollison; Nadia Howlader; Martyn T Smith; Sara S Strom; William D Merritt; Lynn A Ries; Brenda K Edwards; Alan F List
Journal:  Blood       Date:  2008-04-28       Impact factor: 22.113

4.  Clustering in the incidence of myelodysplastic syndromes.

Authors:  Xiaomei Ma; Steve Selvin; Azra Raza; Kathryn Foti; Susan T Mayne
Journal:  Leuk Res       Date:  2007-05-15       Impact factor: 3.156

  4 in total
  2 in total

Review 1.  Rural residence and cancer outcomes in the United States: issues and challenges.

Authors:  Ashley Meilleur; S V Subramanian; Jesse J Plascak; James L Fisher; Electra D Paskett; Elizabeth B Lamont
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10       Impact factor: 4.254

Review 2.  Unraveling Myelodysplastic Syndromes: Current Knowledge and Future Directions.

Authors:  Ali N Chamseddine; Elias Jabbour; Hagop M Kantarjian; Zachary S Bohannan; Guillermo Garcia-Manero
Journal:  Curr Oncol Rep       Date:  2016-01       Impact factor: 5.945

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.